Overview

Endothelial Facilitation in Alzheimer's Disease

Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
Purpose of the study: Patients with mild Alzheimer's Disease will be given three different drugs over a 4-month period to try to increase the blood flow to their brains, and improve blood vessel and brain function. Each drug can help to open the blood vessels in the brain, and together they may be more effective than each drug alone. The hypothesis is that small blood vessels secrete substances that maintain the integrity of the brain, and may prevent loss of nerve cells leading to Alzheimer's Disease
Phase:
Phase 2
Details
Lead Sponsor:
University of Massachusetts, Worcester
Collaborator:
The Glass Foundation
Treatments:
Simvastatin